Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...

The following subsections of the Food and Drugs Act (FDA) set out the supplementary rules authority. Subsection 30.01(1), the authority to set out supplementary rules for a therapeutic product: ...

BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire / -- The Pharmaceutical intermediates market ... detailing their product portfolios, market shares, financial health, regional presence ...

As specialty drugs continue to evolve—particularly those targeting critical diseases such as cancer—the role of pharmaceutical intermediates becomes even ... parties nor do we endorse or guarantee ...

Capitalize on Emerging Biopharmaceutical Trends by integrating specialty intermediates into innovative drug pipelines ... for these third parties nor do we endorse or guarantee their products. We make ...

The import of bulk drugs and drug intermediates to the country has seen a growth of 2.34 per cent in the first nine months of the current fiscal year, as compared to the same period of last year. The ...

Generic drugmakers could be significantly impacted by President Trump's decision to double the tariff on Chinese goods to 20% as a portion of active pharmaceutical ingredients (APIs) used in ...

Furthermore, cutting-edge technologies such as multi-omics are aiding in the discovery of biomarkers and innovative drug targets. Additionally, elucidating the effects of natural products and TCM, ...

On the other hand, India’s imports of bulk drugs and intermediates from the world (overall ... pointed out that the reduction in imports has started for specific products. Before the PLI scheme was ...

Every different combination of antibiotic susceptibility, resistance, or intermediate response to the 13 antibiotics ... Heatmap of the phenotypic characterization of the main multi-drug resistance ...

Understand the decisions to approve or deny the sale of drugs and medical devices in Canada. Research whether a submission for a new drug or a new use for an approved drug has been accepted for review ...